BATRK ATL Braves stock climbs 279 percent despite Q4 2025 EPS miss that fell short of analyst estimates Biogen Inc BIIB Structural Headwinds Justify Avoidance Despite Current Profitability CINF Cincy Fin posts 143 percent Q4 2025 EPS beat yet shares slide 22 percent in todays trading session